2 January 2025 in Nature Communications
Single-cell RNA sequencing (scRNA-seq) is widely used in plant biology and is a powerful tool for studying cell identity and differentiation. However, the scarcity of known cell-type marker genes and the divergence of marker expression patterns limit the accuracy of cell-type identification and our capacity to investigate cell-type conservation in many species. To tackle this challenge, we devise a novel computational strategy called Orthologous Marker Gene Groups (OMGs), which can identify cell types in both model and non-model plant species and allows for rapid comparison of cell types across many published single-cell maps. Our method does not require cross-species data integration, while still accurately determining inter-species cellular similarities. We validate the method by analyzing published single-cell data from species with well-annotated single-cell maps, and we show our methods can capture majority of manually annotated cell types. The robustness of our method is further demonstrated by its ability to pertinently map cell clusters from 1 million cells, 268 cell clusters across 15 diverse plant species. We reveal 14 dominant groups with substantial conservation in shared cell-type markers across monocots and dicots. To facilitate the use of this method by the broad research community, we launch a user-friendly web-based tool called the OMG browser, which simplifies the process of cell-type identification in plant datasets for biologists.
22 January 2026 in Cancer Research
Whole genome doubling (WGD) is a frequent event in cancer evolution associated with chromosomal instability, metastasis, and poor prognosis. Whereas the genomic consequences of WGD are well documented, nongenetic alterations that accompany WGD, such as changes to cell and nuclear size, may also play an important role in tetraploid (4N) cancer cell physiology. In this study, we showed that cell and nuclear volume does not always scale with DNA content after WGD in cancer cells, resulting in 4N cells that differ in size. Small size was associated with enhanced cell fitness, mitotic fidelity, and tumorigenicity in 4N cancer cells and with poor patient survival in WGD-positive human cancers. Overall, these results suggest that cell and nuclear size may contribute to the tumorigenic potential of 4N cancer cells and could be an important prognostic marker in human tumors that undergo WGD. Significance: Cancer cell size varies after whole genome duplication, with smaller cells exhibiting high tumorigenicity and correlating with poor patient survival, demonstrating the clinical relevance and highlighting the biomarker potential of cell size.